We are pleased to announce that we will be hosting a Lhasa Limited Symposium in Seoul, South Korea, alongside BITEK CHEMS.
On 15th October 2024, we will bring together professionals from industry and regulatory bodies to address critical topics in chemical safety, with a particular focus on the ongoing challenges of nitrosamine risk assessment. The event will offer valuable insights from experts on ICH M7 assessment, nitrosamine risk assessment, the application of innovative in silico tools, and the latest regulatory guidance.
External guest speakers include:
- Brian Seo, BITEK CHEMS
- Professor Yong–Moon Lee, Chungbuk National University
- Dr Mike Urquhart, Scientific Director, Drug Substance Development, GSK
- Dr Andrew Teasdale, Senior Principal Scientist, AstraZeneca, and Chair of AstraZeneca’s Impurity Advisory Board
- Dr Raphael Nudelman, Nudelman ChemTox Consulting
- Luccas Sanches, Researcher, Spektra Consultoria
9:00 – 17:00 – Symposium
Session 1: Accelerating ICH M7 Assessment
Session 2: ICH M7: Control of Impurities
Session 3: Nitrosamine Risk Assessment
17:00 – Networking and demonstrations
Simultaneous interpretation and lunch will be provided.
View the full agenda:
Please contact us with any questions.